Through the partnership with TurtleTree, Strive intends to expand its product offerings with an immune support beverage aimed at adults, and a ready-to-mix protein powder, both of which will include TurtleTree’s lactoferrin (LF+).
TurtleTree (Sacramento, CA) has announced a multi-year strategic partnership with Strive (Singapore), a nutrition company focused on sustainable, protein-enriched beverages. Strive currently offers a product called FREEMILK, a dairy milk alternative that contains fermentation-derived protein. Through the partnership with TurtleTree, Strive intends to expand its product offerings with an immune support beverage aimed at adults, and a ready-to-mix protein powder, both of which will include TurtleTree’s lactoferrin (LF+).
“Here at TurtleTree, we are very excited about Strive’s ambitions and goals. We love that they are targeting an industry and segment of a population that is only growing globally and is ripe for more innovation in the market,” said Fengru Lin, CEO, TurtleTree, in a press release. “We are looking forward to supporting Strive with our lactoferrin in order to continue providing their target audience with more functional food products to support longevity.”
Strive’s immune support beverage containing LF+ will come in an 8oz carton with 12-15 grams of fermentation-derived whey protein and 250 mg of LF+, as well as 23 vitamins and minerals geared toward aging adults.
“We created these products for a first launch into adult nutrition for consumers who are concerned about longevity and wellness. The health attributes of bovine lactoferrin and colostrum are extensive and becoming more known to the general public,” said Dennis Cohlmia, CEO of Strive, in a press release. “Now, we can have an animal-free lactoferrin with prebiotics that is made through precision fermentation, vegan-certified, and is cruelty-free. We’ve known the team at Turtle Tree for several years, and have worked closely with them as they have developed the LF+. They are the only company with a commercial product that meets FDA Self-GRAS.”
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.